Clincosm LogoSign in Get a demo

Neoplasms

Showing NaN - NaN of 79
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tumors, Coronavirus Trial in United States

Recruiting
  • Neoplasms
  • Coronavirus
    • Birmingham, Alabama
    • +84 more
    Feb 23, 2022

    Tumors Trial in Canada, United States (GSK3326595, 5-Azacitidine)

    Terminated
    • Neoplasms
    • Birmingham, Alabama
    • +7 more
    Feb 10, 2022

    Ewing Sarcoma, Ewing Family of Tumors, Ewing's Tumor Metastatic Trial in United States (Vigil, Irinotecan, Temozolomide)

    Active, not recruiting
    • Ewing Sarcoma
    • +12 more
    • Vigil
    • +2 more
    • Little Rock, Arkansas
    • +16 more
    Feb 9, 2022

    Human Leukocyte Antigen Typing and Tumor Antigen Expression

    Recruiting
    • Refractory Cancer
    • +3 more
      • Chicago, Illinois
      • +3 more
      Feb 14, 2022

      Urothelial Carcinoma, Urothelial Carcinoma Bladder, Bladder Cancer Trial in United States (IK-175, IK-175 and nivolumab)

      Recruiting
      • Urothelial Carcinoma
      • +20 more
      • Gilbert, Arizona
      • +9 more
      Feb 3, 2022

      Tumors Trial in Worldwide (GSK adoptive cell therapy)

      Recruiting
      • Neoplasms
      • GSK adoptive cell therapy
      • Duarte, California
      • +37 more
      Feb 1, 2022

      Tumors, NUT Carcinoma Trial in Worldwide (BI 894999)

      Completed
      • Neoplasms
      • NUT Carcinoma
      • BI 894999
      • Boston, Massachusetts
      • +15 more
      Dec 3, 2021

      Tumors Trial in Canada, United States (JNJ-63898081)

      Completed
      • Neoplasms
      • San Francisco, California
      • +6 more
      Dec 2, 2021

      Pralsetinib to Best Available Therapy in RET-Fusion Positive

      Enrolling by invitation
      • RET-fusion Non Small Cell Lung Cancer
      • +16 more
        • New York, New York
        • +2 more
        Aug 9, 2021

        Tumors Trial in United States (NY-ESO-1(c259)T Cells, Fludarabine, Cyclophosphamide)

        Completed
        Has Results
        • Neoplasms
        • NY-ESO-1(c259)T Cells
        • +2 more
        • Duarte, California
        • +7 more
        Jun 9, 2021

        Tumors Trial in Worldwide (Everolimus, Sandostatin LAR Depot)

        Completed
        Has Results
        • Neoplasms
        • Little Rock, Arkansas
        • +23 more
        May 17, 2021

        Tumors Trial in Worldwide (GSK525762)

        Completed
        Has Results
        • Neoplasms
        • Little Rock, Arkansas
        • +14 more
        Apr 26, 2021

        Tumors Trial in Worldwide (GSK3174998, Pembrolizumab)

        Completed
        Has Results
        • Neoplasms
        • Boston, Massachusetts
        • +7 more
        Apr 26, 2021

        Tumors Trial in Worldwide (Vemurafenib)

        Completed
        Has Results
        • Neoplasms
        • Rogers, Arkansas
        • +82 more
        Dec 11, 2020

        Tumors, Breast Tumors, Kidney Tumors Trial in Worldwide (alpelisib, everolimus, exemestane)

        Completed
        • Neoplasms
        • +3 more
        • Fayetteville, Arkansas
        • +21 more
        Dec 4, 2020

        Tumors Trial in United Kingdom, United States (GSK2636771, Enzalutamide)

        Completed
        Has Results
        • Neoplasms
        • Duarte, California
        • +8 more
        Sep 28, 2020

        Tumors Trial in United States (PF-06671008)

        Terminated
        Has Results
        • Neoplasms
        • Harrison, New York
        • +8 more
        Apr 27, 2020

        Cancer, Tumors Trial in France, United Kingdom, United States (GSK2816126)

        Terminated
        Has Results
        • Cancer
        • Neoplasms
        • Chicago, Illinois
        • +4 more
        Feb 17, 2020

        Tumors Trial in United States (DLYE5953A)

        Completed
        • Neoplasms
        • Aurora, Colorado
        • +4 more
        Feb 10, 2020

        Tumors Trial in Worldwide (MOXR0916)

        Completed
        • Neoplasms
        • Scottsdale, Arizona
        • +30 more
        Feb 3, 2020

        Tumors Trial in United States (Lupartumab Amadotin (BAY1129980))

        Terminated
        • Neoplasms
        • Lupartumab Amadotin (BAY1129980)
        • La Jolla, California
        • +14 more
        Dec 9, 2019

        Tumors Trial in Worldwide (Rivaroxaban, Placebo)

        Completed
        Has Results
        • Neoplasms
        • Phoenix, Arizona
        • +157 more
        Aug 22, 2019

        Tumors Trial in Worldwide (GSK3052230, paclitaxel, carboplatin)

        Completed
        Has Results
        • Neoplasms
        • Duarte, California
        • +28 more
        Aug 2, 2019

        Cancer, Tumors Trial in Australia, Netherlands, United States (GSK2849330)

        Completed
        Has Results
        • Cancer
        • Neoplasms
        • GSK2849330
        • Aurora, Colorado
        • +13 more
        Apr 4, 2019

        Tumors Trial in United States (IMC-3C5)

        Completed
        Has Results
        • Neoplasms
        • IMC-3C5
        • Peoria, Illinois
        • +3 more
        Mar 11, 2019